A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses

References

• World Health Organization. Malaria. Fact sheet N°94. http://www.who.int/mediacentre/factsheets/fs094/en/ (accessed 19 May 2014).
   Google Scholar
• Roll Back Malaria. Key malaria facts. http://www.rollbackmalaria.org/keyfacts.html (accessed 19 May 2014).
   Google Scholar
• World Health Organization. Guidelines for the treatment of malaria. 2d Ed., 2010. http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf.
   Google Scholar
• Hill AV. Vaccines against malaria. Philos Trans R Soc Lond B Biol Sci 2011; 366:2806 - 14; http://dx.doi.org/10.1098/rstb.2011.0091; PMID: 21893544
   PubMed Web of Science ®Google Scholar
• Thera MA, Plowe CV. Vaccines for malaria: how close are we?. Annu Rev Med 2012; 63:345 - 57; http://dx.doi.org/10.1146/annurev-med-022411-192402; PMID: 22077719
   PubMed Web of Science ®Google Scholar
• Aly ASI, Vaughan AM, Kappe SHI. Malaria parasite development in the mosquito and infection of the mammalian host. Annu Rev Microbiol 2009; 63:195 - 221; http://dx.doi.org/10.1146/annurev.micro.091208.073403; PMID: 19575563
   PubMed Web of Science ®Google Scholar
• Vermeulen AN, Ponnudurai T, Beckers PJ, Verhave JP, Smits MA, Meuwissen JH. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med 1985; 162:1460 - 76; http://dx.doi.org/10.1084/jem.162.5.1460; PMID: 2865324
   PubMed Web of Science ®Google Scholar
• Kaslow DC, Quakyi IA, Syin C, Raum MG, Keister DB, Coligan JE, McCutchan TF, Miller LH. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature 1988; 333:74 - 6; http://dx.doi.org/10.1038/333074a0; PMID: 3283563
   PubMed Web of Science ®Google Scholar
• Samuelson J, Banerjee S, Magnelli P, Cui J, Kelleher DJ, Gilmore R, Robbins PW. The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases. Proc Natl Acad Sci U S A 2005; 102:1548 - 53; http://dx.doi.org/10.1073/pnas.0409460102; PMID: 15665075
   PubMed Web of Science ®Google Scholar
• Barr PJ, Green KM, Gibson HL, Bathurst IC, Quakyi IA, Kaslow DC. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J Exp Med 1991; 174:1203 - 8; http://dx.doi.org/10.1084/jem.174.5.1203; PMID: 1940798
   PubMed Web of Science ®Google Scholar
• Kaslow DC, Bathurst IC, Lensen T, Ponnudurai T, Barr PJ, Keister DB. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect Immun 1994; 62:5576 - 80; PMID: 7960139
   PubMed Web of Science ®Google Scholar
• Zou L, Miles AP, Wang J, Stowers AW. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. Vaccine 2003; 21:1650 - 7; http://dx.doi.org/10.1016/S0264-410X(02)00701-6; PMID: 12639486
   PubMed Web of Science ®Google Scholar
• Wu Y, Przysiecki C, Flanagan E, Bello-Irizarry SN, Ionescu R, Muratova O, Dobrescu G, Lambert L, Keister D, Rippeon Y, et al. Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proc Natl Acad Sci U S A 2006; 103:18243 - 8; http://dx.doi.org/10.1073/pnas.0608545103; PMID: 17110440
   PubMed Web of Science ®Google Scholar
• Qian F, Wu Y, Muratova O, Zhou H, Dobrescu G, Duggan P, Lynn L, Song G, Zhang Y, Reiter K, et al. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates. Vaccine 2007; 25:3923 - 33; http://dx.doi.org/10.1016/j.vaccine.2007.02.073; PMID: 17428587
   PubMed Web of Science ®Google Scholar
• Kubler-Kielb J, Majadly F, Wu Y, Narum DL, Guo C, Miller LH, Shiloach J, Robbins JB, Schneerson R. Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. Proc Natl Acad Sci U S A 2007; 104:293 - 8; http://dx.doi.org/10.1073/pnas.0609885104; PMID: 17190797
   PubMed Web of Science ®Google Scholar
• Qian F, Rausch KM, Muratova O, Zhou H, Song G, Diouf A, Lambert L, Narum DL, Wu Y, Saul A, et al. Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders. Vaccine 2008; 26:2521 - 7; http://dx.doi.org/10.1016/j.vaccine.2008.03.005; PMID: 18423804
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov. Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel. http://www.clinicaltrials.gov/ct2/show/NCT01434381?term=Pfs25-EPA&rank=2 (accessed 30 May 2014).
   Google Scholar
• Rybicki EP. Plant-made vaccines for humans and animals. Plant Biotechnol J 2010; 8:620 - 37; http://dx.doi.org/10.1111/j.1467-7652.2010.00507.x; PMID: 20233333
   PubMed Web of Science ®Google Scholar
• Yusibov V, Streatfield SJ, Kushnir N. Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin 2011; 7:313 - 21; http://dx.doi.org/10.4161/hv.7.3.14207; PMID: 21346417
   PubMed Web of Science ®Google Scholar
• Musiychuk K, Stephenson N, Bi H, Farrance CE, Orozovic G, Brodelius M, Brodelius P, Horsey A, Ugulava N, Shamloul AM, et al. A launch vector for the production of vaccine antigens in plants. Influenza Other Respir Viruses 2007; 1:19 - 25; http://dx.doi.org/10.1111/j.1750-2659.2006.00005.x; PMID: 19453476
   PubMed Web of Science ®Google Scholar
• Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V. Immunogenicity of a subunit vaccine against Bacillus anthracis.. Vaccine 2007; 25:3111 - 4; http://dx.doi.org/10.1016/j.vaccine.2007.01.068; PMID: 17280756
   PubMed Web of Science ®Google Scholar
• Chichester JA, Musiychuk K, Farrance CE, Mett V, Lyons J, Mett V, Yusibov V. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague. Vaccine 2009; 27:3471 - 4; http://dx.doi.org/10.1016/j.vaccine.2009.01.050; PMID: 19200825
   PubMed Web of Science ®Google Scholar
• Mett V, Musiychuk K, Bi H, Farrance CE, Horsey A, Ugulava N, Shoji Y, de la Rosa P, Palmer GA, Rabindran S, et al. A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses 2008; 2:33 - 40; http://dx.doi.org/10.1111/j.1750-2659.2008.00037.x; PMID: 19453491
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Bi H, Musiychuk K, de la Rosa P, Goldschmidt L, Horsey A, Ugulava N, Palmer GA, Mett V, et al. Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine 2008; 26:2930 - 4; http://dx.doi.org/10.1016/j.vaccine.2008.03.045; PMID: 18440103
   PubMed Web of Science ®Google Scholar
• Shoji Y, Bi H, Musiychuk K, Rhee A, Horsey A, Roy G, Green B, Shamloul M, Farrance CE, Taggart B, et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 2009; 27:1087 - 92; http://dx.doi.org/10.1016/j.vaccine.2008.11.108; PMID: 19100806
   PubMed Web of Science ®Google Scholar
• Shoji Y, Farrance CE, Bi H, Shamloul M, Green B, Manceva S, Rhee A, Ugulava N, Roy G, Musiychuk K, et al. Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. Vaccine 2009; 27:3467 - 70; http://dx.doi.org/10.1016/j.vaccine.2009.01.051; PMID: 19200814
   PubMed Web of Science ®Google Scholar
• Shoji Y, Chichester JA, Jones M, Manceva SD, Damon E, Mett V, Musiychuk K, Bi H, Farrance C, Shamloul M, et al. Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum Vaccin 2011; 7:Suppl 41 - 50; http://dx.doi.org/10.4161/hv.7.0.14561; PMID: 21266846
   PubMed Web of Science ®Google Scholar
• Farrance CE, Chichester JA, Musiychuk K, Shamloul M, Rhee A, Manceva SD, Jones RM, Mamedov T, Sharma S, Mett V, et al. Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity. Hum Vaccin 2011; 7:Suppl 191 - 8; http://dx.doi.org/10.4161/hv.7.0.14588; PMID: 21266847
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Yamamoto N, Kano-Murakami Y, Tanaka Y, Ozeki Y, Hirano H, Kagawa H, Oshima M, Ohashi Y. Classification and structural comparison of full-length cDNAs for pathogenesis-related proteins. Plant Physiol 1987; 85:942 - 6; http://dx.doi.org/10.1104/pp.85.4.942; PMID: 16665835
   PubMed Web of Science ®Google Scholar
• malERA Consultative Group on Vaccines. A research agenda for malaria eradication: vaccines. PLoS Med 2011; 8:e1000398; http://dx.doi.org/10.1371/journal.pmed.1000398; PMID: 21311586
   PubMed Web of Science ®Google Scholar
• Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One 2008; 3:e2636; http://dx.doi.org/10.1371/journal.pone.0002636; PMID: 18612426
   PubMed Web of Science ®Google Scholar
• Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malar J 2007; 6:107; http://dx.doi.org/10.1186/1475-2875-6-107; PMID: 17686163
   PubMed Web of Science ®Google Scholar
• Shimp RL Jr., Rowe C, Reiter K, Chen B, Nguyen V, Aebig J, Rausch KM, Kumar K, Wu Y, Jin AJ, et al. Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle. Vaccine 2013; 31:2954 - 62; http://dx.doi.org/10.1016/j.vaccine.2013.04.034; PMID: 23623858
   PubMed Web of Science ®Google Scholar
• Talaat KR, Ellis RD, Durbin AP, Jones DS, Narum DL, MacDonald N, et al. Phase I trial of Pfs25-EPA/Alhydrogel® a transmission blocking vaccine against falciparum malaria in healthy malaria-naïve adults. ASTMH 61st annual Meeting. Atlanta, GA, USA. Nov 11-15, 2012. Abstract #1455.
   Google Scholar
• Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 1967; 6:1948 - 54; http://dx.doi.org/10.1021/bi00859a010; PMID: 6049437
   PubMed Web of Science ®Google Scholar
• Pace CN, Vajdos F, Fee L, Grimsley G, Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 1995; 4:2411 - 23; http://dx.doi.org/10.1002/pro.5560041120; PMID: 8563639
   PubMed Web of Science ®Google Scholar
• Roeffen W, Geeraedts F, Eling W, Beckers P, Wizel B, Kumar N, Lensen T, Sauerwein R. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect Immun 1995; 63:467 - 71; PMID: 7822011
   PubMed Web of Science ®Google Scholar
• Outchkourov N, Vermunt A, Jansen J, Kaan A, Roeffen W, Teelen K, Lasonder E, Braks A, van de Vegte-Bolmer M, Qiu LY, et al. Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. J Biol Chem 2007; 282:17148 - 56; http://dx.doi.org/10.1074/jbc.M700948200; PMID: 17426022
   PubMed Web of Science ®Google Scholar